Clinical Trials Browser

Phase 2/3 × Nausea × Therapeutics × Clear all

NCT03631004 2022-01-13

Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic Patients

Phase 2/3 Completed

Nausea, Vomiting, Postoperative Nausea and Vomiting